These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 28392618)

  • 1. Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery Systems.
    Youngren-Ortiz SR; Gandhi NS; España-Serrano L; Chougule MB
    Kona; 2017; 34():44-69. PubMed ID: 28392618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems.
    Youngren-Ortiz SR; Gandhi NS; España-Serrano L; Chougule MB
    Kona; 2016 Feb; 33():63-85. PubMed ID: 27081214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress.
    Dua K; Wadhwa R; Singhvi G; Rapalli V; Shukla SD; Shastri MD; Gupta G; Satija S; Mehta M; Khurana N; Awasthi R; Maurya PK; Thangavelu L; S R; Tambuwala MM; Collet T; Hansbro PM; Chellappan DK
    Drug Dev Res; 2019 Sep; 80(6):714-730. PubMed ID: 31691339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations.
    Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP
    Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in non-viral localized delivery of siRNA therapeutics for pulmonary diseases.
    Gao J; Xia Z; Vohidova D; Joseph J; Luo JN; Joshi N
    Acta Pharm Sin B; 2023 Apr; 13(4):1400-1428. PubMed ID: 37139423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary drug delivery: from generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challenges.
    Ruge CA; Kirch J; Lehr CM
    Lancet Respir Med; 2013 Jul; 1(5):402-13. PubMed ID: 24429205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulization of siRNA for inhalation therapy based on a microfluidic surface acoustic wave platform.
    Cortez-Jugo C; Masoumi S; Chan PPY; Friend J; Yeo L
    Ultrason Sonochem; 2022 Aug; 88():106088. PubMed ID: 35797825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocarriers for delivery of siRNA as gene silencing mediator.
    Morales-Becerril A; Aranda-Lara L; Isaac-Olivé K; Ocampo-García BE; Morales-Ávila E
    EXCLI J; 2022; 21():1028-1052. PubMed ID: 36110562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Sub-Micron Particle Based Aerosol Strategies for Efficient Systemic Delivery of Therapeutic Agents.
    Joshi N; Kaur S; Banerjee R
    Curr Pharm Des; 2016; 22(17):2470-80. PubMed ID: 26915832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic mucus penetrating microspheres for efficient pulmonary delivery and enhanced efficacy of host defence peptide (HDP) in experimental tuberculosis.
    Sharma A; Vaghasiya K; Gupta P; Singh AK; Gupta UD; Verma RK
    J Control Release; 2020 Aug; 324():17-33. PubMed ID: 32418903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems.
    Dua K; Bebawy M; Awasthi R; Tekade RK; Tekade M; Gupta G; De Jesus Andreoli Pinto T; Hansbro PM
    Pharm Nanotechnol; 2017; 5(4):243-249. PubMed ID: 28786352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Inhaled Chitosan-Based Nanoparticles in Lung Cancer Therapy.
    Silva AC; Costa MP; Zacaron TM; Ferreira KCB; Braz WR; Fabri RL; Frézard FJG; Pittella F; Tavares GD
    Pharmaceutics; 2024 Jul; 16(8):. PubMed ID: 39204314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies.
    Shajari N; Mansoori B; Davudian S; Mohammadi A; Baradaran B
    Curr Drug Deliv; 2017; 14(1):36-46. PubMed ID: 27538460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser-assisted nanocarrier delivery to achieve cutaneous siRNA targeting for attenuating psoriasiform dermatitis.
    Lee WR; Chou WL; Lin ZC; Sung CT; Lin CY; Fang JY
    J Control Release; 2022 Jul; 347():590-606. PubMed ID: 35623494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin inhalation--Pfizer/Nektar Therapeutics: HMR 4006, inhaled PEG-insulin--Nektar, PEGylated insulin--Nektar.
    Drugs R D; 2004; 5(3):166-70. PubMed ID: 15139780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary drug delivery: a role for polymeric nanoparticles?
    d'Angelo I; Conte C; Miro A; Quaglia F; Ungaro F
    Curr Top Med Chem; 2015; 15(4):386-400. PubMed ID: 25579350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry Powder form of Polymeric Nanoparticles for Pulmonary Drug Delivery.
    Shiehzadeh F; Tafaghodi M
    Curr Pharm Des; 2016; 22(17):2549-60. PubMed ID: 26818872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucine improves the aerosol performance of dry powder inhaler formulations of siRNA-loaded nanoparticles.
    Xu Y; Harinck L; Lokras AG; Gerde P; Selg E; Sjöberg CO; Franzyk H; Thakur A; Foged C
    Int J Pharm; 2022 Jun; 621():121758. PubMed ID: 35483619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary delivery of therapeutic siRNA.
    Lam JK; Liang W; Chan HK
    Adv Drug Deliv Rev; 2012 Jan; 64(1):1-15. PubMed ID: 21356260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
    Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.